Peri-implant inflammation: a catalyst for bisphosphonate-related osteonecrosis?

While bisphosphonates (BP) remain essential in the management of bone pathologies, their association with medication-related osteonecrosis of the jaw (MRONJ) represents a critical risk in implantology. The challenge for the practitioner lies in managing local inflammatory triggers, particularly peri-implantitis, whose interaction with BPs remains to be precisely elucidated.

This experimental study, conducted on a murine model of 24 mice, explores the combined impact of zoledronic acid (ZA) and ligature-induced peri-implant inflammation. The objective was to analyze the tissue and bone alterations following this dual aggression on maxillary extraction and implant placement sites.

The authors tested the hypothesis that peri-implant inflammation significantly increases the risk of MRONJ under anti-resorptive treatment. The study aimed to compare, via micro-CT and histology, the levels of bone loss, inflammatory infiltration, and the presence of empty osteocyte lacunae — pathognomonic signs of necrosis — between groups treated with ZA or a control vehicle.

Experimental protocol and methodology

This in vivo study was conducted on a model of 24 mice that underwent bilateral maxillary molar extractions followed by dental implant placement. The objective was to analyze the interaction between systemic bisphosphonate treatment and localized peri-implant inflammation.

The samples were divided into two main groups defined by the nature of the treatment administered:

• Group 1 (Vehicle): Mice treated with a control solution, including control sites (Veh-C) and ligature sites (Veh-L).
• Group 2 (ZA): Mice treated with zoledronic acid, including control sites (ZA-C) and sites with ligature (ZA-L).

Inflammation was induced by the placement of a ligature on the left side of each subject. The evaluation of the results was based on a multidimensional approach:

• Micro-CT Imaging: Precise quantification of peri-implant bone loss.
• Histological Analysis: Evaluation of the inflammatory infiltrate and identification of empty osteocyte lacunae. Picrosirius red staining was used to analyze the organization of collagen fibers.
• Immunohistochemistry: Specific quantification of neutrophils (NIMP-R14+) and monocytes/macrophages (CD11b+).

The protocol also included clinical follow-up to document the evolution of soft tissue edema at the implant sites.

Clinical and Radiographic Analysis (Micro-CT)

Clinical evaluation revealed a marked increase in soft tissue edema in both ligature groups (Veh-L and ZA-L) compared to the control groups. Notably, no significant difference was observed between the vehicle treatment and the zoledronic acid (ZA) treatment regarding the extent of this edema.

Micro-CT analysis highlighted major variations in peri-implant bone resorption:

• The Veh-L group (vehicle + ligature) showed significantly greater bone loss than all other groups in the study.
• The administration of zoledronic acid appears to have modulated macroscopic bone loss, although the qualitative tissue risk remained high.

Histology and Tissue Integrity

Histological analyses have identified specific markers of medication-related osteonecrosis of the jaw (MRONJ) induced by bisphosphonates (BPs). The results are summarized in the following table:

Immunohistochemistry and Cellular Profile

The study of the local immune response showed a direct correlation between the presence of the ligature and inflammatory cellular recruitment. Immunohistochemical markers revealed:

• A significant increase in neutrophils (NIMP-R14+) and monocytes/macrophages (CD11b+) in the groups with ligation (Veh-L and ZA-L).
• The absence of a significant difference between the control groups Veh-C and ZA-C, suggesting that zoledronic acid alone, without local inflammatory stimulus, does not significantly alter the baseline peri-implant immune profile.

These data confirm that while ligation triggers inflammation, interaction with zoledronic acid exacerbates structural bone damage, leading to a significant increase in signs of osteonecrosis.

Peri-implant inflammation: the trigger for osteonecrosis

The results of this experimental study (n=24 mice) reveal a critical pathological synergy between zoledronic acid (ZA) and local inflammation. While inflammation alone (Veh-L group) induces significant bone loss through resorption, it is the addition of ZA that shifts the phenotype toward osteonecrosis. In the ZA-L group, histological analysis shows a predominance of empty osteocyte lacunae and major disorganisation of collagen fibres, confirming that bisphosphonate (BPs) treatment alters the structural quality of the bone in the presence of inflammatory stimuli.

The study highlights that soft tissue edema is constant during ligature placement, regardless of drug treatment. However, the local immune response is exacerbated: the massive infiltration of neutrophils (NIMP-R14+) and monocytes/macrophages (CD11b+) in the ligature groups suggests that peri-implant inflammation acts as a biological catalyst for MRONJ. This observation validates the authors' hypothesis: the presence of a local inflammatory trigger is necessary to initiate necrotic complications related to BPs.

Clinical limitations and implications

Although this murine model allows for the precise isolation of cellular mechanisms, its experimental nature limits the direct transposition of healing times to humans. However, the correlation between inflammation and necrosis is unequivocal here. In the dental practice, these data indicate that managing peri-implant health in patients on BPs is not only a matter of implant longevity, but a necessity to prevent a serious systemic complication.

Study summary

This murine model study demonstrates that the combination of zoledronic acid and ligature-induced peri-implant inflammation causes a significant increase in empty osteocyte lacunae and necrotic areas. Although quantitative bone loss is paradoxically more pronounced without bisphosphonates, inflammation under treatment severely alters collagen microstructure and bone viability, drastically increasing the risk of MRONJ.

In concrete terms, for the practitioner:

• Zero inflammatory tolerance: Soft tissue inflammation is the critical trigger for osteonecrosis; its strict control prevails over simple monitoring of bone loss in patients on bisphosphonates.
• Proactive monitoring: Increase the frequency of follow-ups to ensure early detection of any oedema or inflammatory infiltration, even in the absence of radiological signs of resorption.
• Trigger prevention: Systematically eliminate any local irritants (plaque, cement excess) to reduce inflammatory mediators (neutrophils, macrophages) that exacerbate the deleterious effects of bisphosphonates on peri-implant bone.

Technical Lexicon of the Study

MRONJ (Medication-Related Osteonecrosis of the Jaw): Medication-related osteonecrosis of the jaw. This is a serious bone complication characterized by a lack of healing and bone exposure, the risk of which is significantly exacerbated in this study by the synergy between bisphosphonates and peri-implant inflammation.

Zoledronic acid (ZA): High-potency bisphosphonate with anti-resorptive properties. In this experimental model, ZA administration is identified as a determining factor in the pathogenesis of osteonecrosis when a local inflammatory stimulus is present.

Micro-CT (Micro-tomography): High-resolution three-dimensional imaging method used for the structural analysis of mineralised tissues. It has allowed for the precise quantification of alveolar bone loss around dental implants.

Empty osteocytic lacunae: Histological marker of bone necrosis corresponding to bone lacunae devoid of living osteocytes. The study shows that their number is significantly higher in the group combining ZA treatment and induced inflammation.

NIMP-R14+: Specific immunohistochemical marker used to identify and quantify neutrophil infiltration within peri-implant tissues, reflecting the intensity of the acute inflammatory response.

CD11b+: Cell surface marker expressed by monocytes and macrophages. Its detection allowed for the evaluation of the recruitment of chronic inflammatory myeloid cells around implant sites.

Picrosirius red staining: Histological staining technique used to evaluate the organization of collagen fibers. The study reports structural disorganization and separation of collagen fibers specifically in the ZA-L group.

Information intended for healthcare professionals. This content may contain errors or truncated summaries. We recommend always verifying with the original source article. Delynov disclaims all responsibility for the use of this information. This document is not intended for patients or the general public.